CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Differences between the left main and other bifurcations Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Advances in therapeutic interventions for patients with pulmonary arterial hypertension

Original ResearchVolume 73, Issue 18, 14 May 2019, Pages 2267-2282

JOURNAL:J Am Coll Cardiol. Article Link

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure

CK Nagaraju, EL Robinson, KR Sipido et al. Keywords: contractile function extracellular matrix fibroblasts inflammation

FULL TEXT PDF